Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Holdings
Novo Holdings
Backlash builds against Novo’s Catalent takeover
Pharma Voice
Wed, 10/30/24 - 11:40 am
Novo Holdings
Novo Nordisk
Catalent
M&A
Roche
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
Fierce Pharma
Wed, 10/23/24 - 10:26 pm
Roche
Novo Holdings
Catalent
CDMOs
M&A
drug manufacturing
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout
Reuters
Mon, 10/21/24 - 09:41 am
Catalent
Alessandro Maselli
Novo Holdings
M&A
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Fierce Pharma
Fri, 10/18/24 - 11:26 am
Novo Holdings
Catalent
FTC
M&A
Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration
Fierce Biotech
Thu, 10/10/24 - 11:21 am
Booster Therapeutics
funding
targeted protein degradation
Novo Holdings
Oxford Nanopore rises on Novo Holdings equity stake
Pharmaphorum
Thu, 08/1/24 - 11:09 am
Oxford Nanopore
Novo Holdings
Novo Nordisk
Novo leads $100m financing for Alzheimer's player Asceneuron
Pharmaphorum
Tue, 07/16/24 - 11:56 am
Novo Holdings
Asceneuron
funding
Alzheimer's disease
FTC request may signal trouble for Novo/Catalent deal
Pharma Voice
Thu, 05/30/24 - 11:09 am
Novo Holdings
Catalent
FTC
M&A
Novo Nordisk-owner to expand in India this year
Reuters
Tue, 03/12/24 - 06:50 pm
Novo Nordisk
Novo Holdings
India
Novo Nordisk's controlling shareholder plans to invest about $35 bln by 2030
Reuters
Mon, 02/12/24 - 11:19 pm
Novo Nordisk
Novo Holdings
Lilly, Novo, BMS return to boost BGV's largest European biotech fund yet
Fierce Biotech
Thu, 07/13/23 - 10:15 am
Eli Lilly
Novo Holdings
Bristol Myers Squibb
venture capital
funding
BGV
Europe
Activist investor NexPoint threatens to block Paratek's $462M sale
Fierce Pharma
Wed, 06/28/23 - 10:31 pm
Paratek
Novo Holdings
NexPoint
activist investors
Novo Holdings picks up injectables CDMO in push for single-use manufacturing tech
Endpoints
Thu, 01/6/22 - 11:55 pm
Novo Holdings
CDMOs
M&A
Ritedose
Eyeing clinical proof-of-concept for HER3 drug, Amgen-partnered biotech scores $125M for precision antibodies
Endpoints
Tue, 05/18/21 - 11:28 pm
Singapore
Novo Holdings
precision antibodies
Hummingbird Biosciences
BioGeneration Ventures closes 4th fund, with $170M in tow for early European biotechs
Fierce Biotech
Thu, 01/7/21 - 11:04 pm
BioGeneration Ventures
venture capital
Europe
Bristol Myers Squibb
Eli Lilly
Novo Holdings
Novo invests in Hemab, a company going against the hemophilia gene therapy grain with a plan for bispecifics
Endpoints
Mon, 12/14/20 - 10:53 am
Novo Nordisk
Novo Holdings
Hemab
hemophilia
After years of partnerships, AI biotech Exscientia lands first major financing round at $60M
Endpoints
Tue, 05/26/20 - 11:04 am
artificial intelligence
Exscientia
Novo Holdings
Novo Holdings tweaks fund to take antibiotics deeper into the clinic
Fierce Biotech
Mon, 01/6/20 - 10:19 am
Novo Holdings
antibiotics
drug development
Glycomine looks toward clinic with Novo-led $33M round
BioCentury
Wed, 08/7/19 - 11:39 pm
Glycomine
Novo Holdings
PMM2-CDG
Novo Holdings' antibiotic resistance fund backs 3 biotechs
Fierce Biotech
Mon, 01/21/19 - 12:32 pm
Novo Nordisk
Novo Holdings
antibiotic resistance
Minervax
Procarta Biosystems
Entasis Therapeutics